NAD+ vs MOTS-C: A Cellular-Longevity Research Comparison
A neutral research overview comparing a coenzyme and a mitochondrial-derived peptide studied in cellular-longevity and metabolic research models.
NAD+ and MOTS-C are both studied in cellular-longevity and metabolic research, but they are fundamentally different types of molecule: a coenzyme versus a mitochondrial-derived peptide. This overview compares what each is in research terms.
| NAD+ | MOTS-C | |
|---|---|---|
| Type | Coenzyme (nicotinamide adenine dinucleotide) | Mitochondrial-derived peptide |
| Research focus | Energy metabolism, DNA-repair, and longevity models | Mitochondrial signalling and metabolic-stress models |
| Origin | Naturally occurring coenzyme | Peptide encoded in mitochondrial DNA |
| Format | Lyophilised vial | Lyophilised vial |
NAD+ — research overview
NAD+ is a coenzyme central to energy metabolism and studied in models of DNA repair and cellular longevity. See our note on NAD+ cellular-longevity research.
MOTS-C — research overview
MOTS-C is a mitochondrial-derived peptide studied in models of mitochondrial signalling and metabolic stress. See our overview of MOTS-C and DSIP research.
Key differences researchers note
The core distinction is coenzyme versus peptide: NAD+ research centres on a fundamental metabolic cofactor, while MOTS-C research centres on a signalling peptide encoded in mitochondrial DNA. Both intersect the mitochondrial and metabolic research space, which is why they are sometimes studied together.
Research considerations
Both are third-party tested with a published Certificate of Analysis — verify a batch or review the Quality Report.
*Research use only. NAD+ and MOTS-C are sold strictly for in vitro laboratory research and are not for human or veterinary use.*